481 related articles for article (PubMed ID: 15336966)
1. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy.
Wilkins BJ; Molkentin JD
Biochem Biophys Res Commun; 2004 Oct; 322(4):1178-91. PubMed ID: 15336966
[TBL] [Abstract][Full Text] [Related]
2. Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs.
Molkentin JD
Cardiovasc Res; 2004 Aug; 63(3):467-75. PubMed ID: 15276472
[TBL] [Abstract][Full Text] [Related]
3. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD
Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416
[TBL] [Abstract][Full Text] [Related]
4. Interference of antihypertrophic molecules and signaling pathways with the Ca2+-calcineurin-NFAT cascade in cardiac myocytes.
Fiedler B; Wollert KC
Cardiovasc Res; 2004 Aug; 63(3):450-7. PubMed ID: 15276470
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes.
Fiedler B; Lohmann SM; Smolenski A; Linnemuller S; Pieske B; Schroder F; Molkentin JD; Drexler H; Wollert KC
Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11363-8. PubMed ID: 12177418
[TBL] [Abstract][Full Text] [Related]
6. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.
Wilkins BJ; Dai YS; Bueno OF; Parsons SA; Xu J; Plank DM; Jones F; Kimball TR; Molkentin JD
Circ Res; 2004 Jan; 94(1):110-8. PubMed ID: 14656927
[TBL] [Abstract][Full Text] [Related]
7. Remodeling muscles with calcineurin.
Olson EN; Williams RS
Bioessays; 2000 Jun; 22(6):510-9. PubMed ID: 10842305
[TBL] [Abstract][Full Text] [Related]
8. Reversal of cardiac hypertrophy in transgenic disease models by calcineurin inhibition.
Lim HW; De Windt LJ; Mante J; Kimball TR; Witt SA; Sussman MA; Molkentin JD
J Mol Cell Cardiol; 2000 Apr; 32(4):697-709. PubMed ID: 10756124
[TBL] [Abstract][Full Text] [Related]
9. Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides.
Tokudome T; Horio T; Kishimoto I; Soeki T; Mori K; Kawano Y; Kohno M; Garbers DL; Nakao K; Kangawa K
Circulation; 2005 Jun; 111(23):3095-104. PubMed ID: 15939815
[TBL] [Abstract][Full Text] [Related]
10. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo.
Passier R; Zeng H; Frey N; Naya FJ; Nicol RL; McKinsey TA; Overbeek P; Richardson JA; Grant SR; Olson EN
J Clin Invest; 2000 May; 105(10):1395-406. PubMed ID: 10811847
[TBL] [Abstract][Full Text] [Related]
11. NFAT transcription factors are critical survival factors that inhibit cardiomyocyte apoptosis during phenylephrine stimulation in vitro.
Pu WT; Ma Q; Izumo S
Circ Res; 2003 Apr; 92(7):725-31. PubMed ID: 12663489
[TBL] [Abstract][Full Text] [Related]
12. cAMP-binding protein Epac induces cardiomyocyte hypertrophy.
Morel E; Marcantoni A; Gastineau M; Birkedal R; Rochais F; Garnier A; Lompré AM; Vandecasteele G; Lezoualc'h F
Circ Res; 2005 Dec; 97(12):1296-304. PubMed ID: 16269655
[TBL] [Abstract][Full Text] [Related]
13. Calcineurin activation is not necessary for Doxorubicin-induced hypertrophy in H9c2 embryonic rat cardiac cells: involvement of the phosphoinositide 3-kinase-Akt pathway.
Merten KE; Jiang Y; Feng W; Kang YJ
J Pharmacol Exp Ther; 2006 Nov; 319(2):934-40. PubMed ID: 16926266
[TBL] [Abstract][Full Text] [Related]
14. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S
Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042
[TBL] [Abstract][Full Text] [Related]
15. The DnaJ-related factor Mrj interacts with nuclear factor of activated T cells c3 and mediates transcriptional repression through class II histone deacetylase recruitment.
Dai YS; Xu J; Molkentin JD
Mol Cell Biol; 2005 Nov; 25(22):9936-48. PubMed ID: 16260608
[TBL] [Abstract][Full Text] [Related]
16. Calcineurin Abeta gene targeting predisposes the myocardium to acute ischemia-induced apoptosis and dysfunction.
Bueno OF; Lips DJ; Kaiser RA; Wilkins BJ; Dai YS; Glascock BJ; Klevitsky R; Hewett TE; Kimball TR; Aronow BJ; Doevendans PA; Molkentin JD
Circ Res; 2004 Jan; 94(1):91-9. PubMed ID: 14615291
[TBL] [Abstract][Full Text] [Related]
17. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1.
Musarò A; McCullagh KJ; Naya FJ; Olson EN; Rosenthal N
Nature; 1999 Aug; 400(6744):581-5. PubMed ID: 10448862
[TBL] [Abstract][Full Text] [Related]
18. Calcineurin and beyond: cardiac hypertrophic signaling.
Molkentin JD
Circ Res; 2000 Oct; 87(9):731-8. PubMed ID: 11055975
[TBL] [Abstract][Full Text] [Related]
19. The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice.
Chiang CS; Huang CH; Chieng H; Chang YT; Chang D; Chen JJ; Chen YC; Chen YH; Shin HS; Campbell KP; Chen CC
Circ Res; 2009 Feb; 104(4):522-30. PubMed ID: 19122177
[TBL] [Abstract][Full Text] [Related]
20. Activation of the Ca(2+)/calcineurin/NFAT2 pathway controls smooth muscle cell differentiation.
Larrieu D; Thiébaud P; Duplàa C; Sibon I; Thézé N; Lamazière JM
Exp Cell Res; 2005 Oct; 310(1):166-75. PubMed ID: 16129432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
